Rebuttal Letter to the Editor Kloosterboer et al., Ther Drug Monit 2018;40: 344-350

Sanne Kloosterboer; Brenda de Winter; Soma Bahmany; Linda Al-Hassany; A Dekker; Gwen Dieleman; Teun Gelder; Bram Dierckx; Birgit Koch

doi:10.1097/FTD.0000000000000560

Rebuttal Letter to the Editor Kloosterboer et al., Ther Drug Monit 2018;40: 344-350

Sanne Kloosterboer, Brenda de Winter, Soma Bahmany, Linda Al-Hassany, A Dekker, Gwen Dieleman, Teun Gelder, Bram Dierckx, Birgit Koch

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	762
Journal	Therapeutic Drug Monitoring
Volume	40
Issue number	6
DOIs	https://doi.org/10.1097/FTD.0000000000000560
Publication status	Published - 2018

Research programs

EMC OR-01

Access to Document

10.1097/FTD.0000000000000560

Cite this

@article{13696dac38f1482cb168286abe6f5c02,

title = "Rebuttal Letter to the Editor Kloosterboer et al., Ther Drug Monit 2018;40: 344-350",

author = "Sanne Kloosterboer and {de Winter}, Brenda and Soma Bahmany and Linda Al-Hassany and A Dekker and Gwen Dieleman and Teun Gelder and Bram Dierckx and Birgit Koch",

year = "2018",

doi = "10.1097/FTD.0000000000000560",

language = "Undefined/Unknown",

volume = "40",

pages = "762",

journal = "Therapeutic Drug Monitoring",

issn = "0163-4356",

publisher = "Lippincott Williams & Wilkins",

number = "6",

}

TY - JOUR

T1 - Rebuttal Letter to the Editor Kloosterboer et al., Ther Drug Monit 2018;40: 344-350

AU - Kloosterboer, Sanne

AU - de Winter, Brenda

AU - Bahmany, Soma

AU - Al-Hassany, Linda

AU - Dekker, A

AU - Dieleman, Gwen

AU - Gelder, Teun

AU - Dierckx, Bram

AU - Koch, Birgit

PY - 2018

Y1 - 2018

U2 - 10.1097/FTD.0000000000000560

DO - 10.1097/FTD.0000000000000560

M3 - Article

C2 - 30444494

SN - 0163-4356

VL - 40

SP - 762

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

IS - 6

ER -